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and Acronyms
ADP = adenosine
diphosphate
AF = atrial ﬁbrillation
ATP = adenosine
triphosphate
BMI = body mass index
CABG = coronary artery
bypass graft
mCRC = mitochondrial
calcium retention capacity
MnSOD = manganese
superoxide dismutase
mPTP = mitochondrial
permeability transition pore
OXPHOS = oxidative
phosphorylation
POAF = post-operative atrial
ﬁbrillation
ROS = reactive oxygen
species
SR = sinus rhythm
VCox = complex IV–related
uncoupled maximum
respiration
VpalmþADP = adenosine
diphosphate–stimulated
respiration supported by
palmitoyl-L-carnitine
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1467cardiomyocyte excitability and cell-to-cell coupling through
the regulation of the adenosine monophosphate protein kinase
(3), the adenosine triphosphate–sensitive potassium channel
(4), the sarcolemmal sodium channel (5,6).
Atrialﬁbrillation (AF) is themost common sustained cardiac
arrhythmia. AF is a frequent complication of cardiac surgery,
with the incidence ranging from 10% to 60% (7). Post-opera-
tive atrial ﬁbrillation (POAF) is associated with signiﬁcant
increased morbidity and mortality (8,9). Although risk factors
for POAF have been identiﬁed (i.e., advanced age, structural
heart disease, metabolic syndrome, obesity), the pathological
mechanisms responsible for the onset and perpetuation of
POAF are incompletely understood (7).
See page 1474
We designed a prospective study exploring the relation-
ship between POAF onset, pre-operative mitochondrial
function (i.e., mitochondrial respiration, complex activity
and calcium retention capacity, myocardial oxidative stress),
and the atrial transcriptome in patients in sinus rhythm (SR)
with metabolic syndrome who underwent coronary artery
bypass graft (CABG) surgery. Thus, we provide insights
into the potential link between mitochondria and arrhythmia
by exploring relevant human atrial tissue through pre-
operative biopsies just few hours before arrhythmia onset in
a population at high risk of atrial arrhythmia (7).
Methods
Patient selection and data collection. From September
2010 to March 2012, patients hospitalized in the heart
surgery ward at Lille University Regional Hospital for
CABG surgery were included in the study only if they had
metabolic syndrome, diagnosed when 3 of the 5 following
criteria were present: 1) waist circumference>102 cm in men
and >88 cm in women; 2) fasting glycemia level >1 g/l;
3) triglyceride level >1.5 g/l; 4) high-density lipoprotein
cholesterol <0.4 g/l in men and <0.5 g/l in women; and
5) hypertension (10). Other inclusion criteria were as follows:
patients undergoing on-pump CABG surgery with removal
of the right atrial appendage and SR at the time of inclusion.
Exclusion criteria were a history of AF or current treatment
with class I or III antiarrhythmic drugs, signiﬁcant valvular
disease, left ventricular ejection fraction <50%, patients
younger than 18 years of age, or emergency procedure
surgery. Clinical, biological, and echocardiographic data of
included patients were obtained from the pre-operative
consult. POAF was deﬁned as AF lasting >30 s, recorded
by continuous wireless rhythmic monitoring, that began
immediately after surgery and lasted 8 days. Electrocardio-
graphic data were stored and analyzed after patient discharge.
Patients provided informed consent. This study has received
authorization from the local Patient Protection Committee.
Atrial appendage biopsy and tissue processing. Human
atrial tissue samples were obtained from right atrialappendages before cardiopulmo-
nary bypass (11). Samples were
immediately collected in an ice-
cold cardioplegic solution for
functional studies, with the rest
of the tissue biopsy being snap-
frozen.
Mitochondrial functional studies
and in vitro chain complex acti-
vities. PERMEABILIZED MYOCAR-
DIAL FIBER PREPARATION. Thin
bundles were separated along
atrial trabeculae orientation under
stereomicroscopic control in ice-
cold BIOPS relaxing solution con-
taining 2.77 mM CaK2-ethylene
glycol-bis(b-aminoethyl ether)-N,
N,N0,N0-tetraacetic acid (EGTA),
7.23 mM K2EGTA, 6.56 mM
MgCl2, 0.5 mM dithiothreitol,
50 mM K-2-(N-Morpholino)
ethanesulfonic acid (MES), 20
mM imidazole, 20 mM taurine,
5.3 mM Na2-adenosine tripho-
sphate (ATP), 15 mM phos-
phocreatine, pH 7.1. Bundles
were then permeabilized for 30
min with saponin solution and
washed 3 times for 5 min in respi-
rationmediumMiRO5 containing
110 mM sucrose, 20 mM 4-(2-Hydroxyethyl)piperazine-
1-ethanesulfonic acid, 10 mM KH2PO4, 20 mM taurine,
3 mM MgCl26H2O, 60 mM MES-K, 0.5 mM EGTA,
and 0.1% bovine serum albumin; pH 7.1.
HIGH-RESOLUTION RESPIROMETRY. Respiration rates were
measured at 37C with different substrates and inhibitors in
atrial permeabilized ﬁbers, as described previously (11,12).
Mitochondrial O2 consumption measurements were made
using the O2K oxygraph (Oroboros, Innsbruck, Austria).
Substrate and inhibitors for respiratory experiments were
added to MiRO5 in a step-by-step manner using micro
syringes. Chemical agents were sequentially administered.
At the end of each experiment, respirometer chambers were
calibrated for zero O2 content with dithionite. Respiration
rates were expressed in pmolO2$s
1$mg dry wt1.
Two mitochondrial substrate/inhibitor protocols were
applied. In the carbohydrate protocol, substrate combina-
tions were used for electron ﬂow through respiratory chain
complexes I and II (Fig. 1A). Complex I–dependent
respiration (respiration supported by pyruvate and malate
in the absence of adenosine diphosphate) was determined
in the presence of 10 mM pyruvate þ 2 mM malate with-
out ADP. Complex I–dependent respiration (adenosine
diphosphate–stimulated respiration supported by pyruvate
and malate) was determined as a phosphorylation-stimulated
Figure 1
Pre-Operative Mitochondrial Function in Patients in
Whom POAF Is or Is Not Developing, Assessed by
O2 Consumption Rates in Permeabilized Atrial Fibers
(A) Representative oxygraph trace of a typical O2 consumption using a substrate/
inhibitor combination, as described in the carbohydrate protocol (details in the
Methods section). (B) Respiration rates in carbohydrate and fatty acid protocols in
patients in whom POAF is or is not developing. Five to 7 ﬁbers were explored per
protocol for each of the 104 patients. Values are presented as mean  SD.
*p < 0.05 versus sinus rhythm. #p < 0.01 versus sinus rhythm. ADP ¼ adenosine
diphosphate; FCCP ¼ carbonylcyanide-p-triﬂuoromethoxyphenylhydrazone;
KCN ¼ potassium cyanide; POAF ¼ post-operative atrial ﬁbrillation; SR ¼ sinus
rhythm; TMPD ¼ N,N,N9,N9-tetramethyl-p-phenylenediamine; VCox ¼ complex
IV–related uncoupled maximum respiration; Vpalm ¼ respiration supported by
palmitoyl-L-carnitine in the absence of ADP; VpalmþADP ¼ ADP-stimulated respiration
supported by palmitoyl-L-carnitine; VpyrþADP ¼ ADP-stimulated respiration
supported by pyruvate and malate; Vpyrþmal ¼ respiration supported by pyruvate
and malate in the absence of ADP; VsuccþADP ¼ ADP-stimulated complex
II–dependent respiration.
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1468respiration rate in the presence of 5 mM ADP. In all
groups, the lack of a signiﬁcant increase in respiration after
addition of cytochrome c (10 mM) conﬁrmed the integrity
of the outer mitochondrial membrane. Subsequently,
complex I was inhibited by rotenone (0.5 mM) and complex
II–dependent respiration (adenosine diphosphate–stimulated
complex II–dependent respiration) was determined in the
presence of 10 mM succinate. The complex IV–dependent
uncoupled state of respiration (VCox) was determined in
presence of 2 mM ascorbate, 0.5 mM N,N,N9,N9-tetramethyl-p-phenylenediamine (TMPD), the complex
III inhibitor antimycin A (2.5 mM), and the oxidative
phosphorylation uncoupler carbonylcyanide-p-triﬂuoro-
methoxyphenylhydrazone (FCCP) (2 mM) (VTMPD-asc).
TMPD-ascorbate auto-oxidation (VKCN) was determined as
the O2 consumption in the presence of 1 mM potassium
cyanide (KCN) added to the VTMPD-asc medium. VCox was
calculated as VTMPD-asc  VKCN. Because antimycin A
inhibits complex III, VCox estimated the complex IV–related
uncoupled maximum respiration rate.
In the fatty acid protocol, respiration was measured with
palmitoyl-L-carnitine (80 mM) and malate (2 mM) (respi-
ration supported by palmitoyl-L-carnitine in the absence of
ADP) followed by ADP (5 mM) (adenosine disphosphate–
stimulated respiration supported by palmitoyl-L-carnitine
[VpalmþADP]) feeding electrons into electron-transferring
ﬂavoprotein and complex I.
MITOCHONDRIAL CALCIUM RETENTION CAPACITY. The
mitochondrial calcium retention capacity (mCRC) was
determined as the capacity of mitochondria to uptake
calcium before permeability transition to test the sensitivity
of the mitochondrial permeability transition pore (mPTP)
opening to calcium. Calcium uptake of permeabilized ﬁbers
(ADP-deprived buffer) was quantiﬁed by monitoring
calcium green (1 mM) ﬂuorescence at 506 to 535 nm in
response to 4-nmol pulses of exogenous Ca2þ, as previously
described (13). mCRC was expressed as total mitochondrial
calcium retention in nmolCa2þ$mg dry wt1.
IN VITRO CHAIN COMPLEX ACTIVITIES. Citrate synthase and
electron transport chain complex activities (complexes I,
IIþIII, III, and IV) were performed as described in Online
Appendix 1.
Myocardial oxidative stress. Reactive oxygen species
(ROS) concentrations were measured in frozen tissue by
electron paramagnetic resonance spectroscopy, as previously
described (14). Manganese superoxide dismutase (MnSOD)
and catalase activities were assayed as previously described
(15) and expressed as U$mg1 (Online Appendix 1).
Transcriptomic study. Pre-operative right atrial tissues
were selected from 8 patients in whom POAF developed
and matched to 8 patients without POAF (Online Table 1
in Online Appendix 1). Total RNA was extracted and
analyzed with Agilent SurePrint G3 Human Gene Expres-
sion 8x60K v2, as described in Online Appendix 1.
Statistical analysis. Continuous variables with a Gaussian
distribution are given as mean  SD. Continuous variables
with no Gaussian distribution are given as median (25th to
75th) percentiles. Categorical variables are given as the
percentage (number) of patients with the respective attri-
bute. Bivariate comparisons were performed using the t test
for normally distributed continuous variables or the Mann-
Whitney U test for variables not normally distributed.
Bivariate comparisons of categorical variables were per-
formed with the chi-square test. Potential predictors for
POAF onset with a p value <0.15 on bivariate analysis (age,
Table 1 Patient Characteristics
Variables
SR Patients
(n ¼ 58)
POAF Patients
(n ¼ 46) p Value
Age, yrs 64.5  10 69  8 0.06
Male 40 (69) 30 (65) 0.83
BMI, kg/m2 29.8  4.1 32.1  5.4 0.03
Waist circumference, cm 114  10 116  12 0.49
Systolic blood pressure, 137  12 134  16 0.36
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1469body mass index [BMI], heart rate, and VpalmþADP) were
added to the multivariate stepwise logistic regression model
using backward variable selection. Beta-blocker and statin
medications were also forced into the model because of their
clinical relevance. Odds ratios are given with 95% conﬁdence
intervals for categorical variables. Coefﬁcients and SDs are
given for continuous variables. All analyses were conducted
using SAS version 9.2 (SAS Institute, Cary, North Carolina).mm Hg
Diastolic blood pressure,
mm Hg
74  9 73  12 0.50
Heart rate, beats/min 67  9 79  14 <0.01
Comorbidities
Hypertension 54 (93) 40 (86) 0.33
Diabetes 32 (55) 31 (67) 0.23
Dyslipidemia 46 (79) 33 (72) 0.49
Current smoker 12 (21) 13 (28) 0.49
Euroscore 3.2  1.1 3.4  0.9 0.61
Laboratory data
Creatinine, mg/l 9.8  2.4 10.1  0.9 0.66
Glycosylated
hemoglobin, %
7.1  1.3 6.9  0.9 0.17
HDL, g/l 0.32 (0.26–0.53) 0.37 (0.30–0.46) 0.28
LDL, g/l 1.00 (0.85–1.29) 0.90 (0.73–1.16) 0.32
TG, g/l 1.38 (0.97–2.67) 1.42 (1.16–2.48) 0.52
ECG and
echocardiographic
data
P-wave duration, ms 111  28 105  21 0.67
Sokolow-Lyon index,
mm
19.0 (16–26) 17.8 (15–24) 0.29
LVEF, % 59  8 60  8 0.78
LA diameter, mm 39.5  6 38.9  6 0.67
Time on bypass, min 96  30 94  27 0.79
Pre-operative medication
Statins 53 (90) 40 (86) 0.53
Diuretics 12 (21) 10 (22) 1.00
ACE inhibitors or ARBs 50 (86) 40 (87) 1.00
Beta-blockers 44 (76) 32 (69) 0.51
Antiplatelet agent 57 (98) 46 (100) 1.00
Oral anticoagulant 1 (2) 2 (4) 0.58
Insulin 2 (3) 2 (4) 1.00
Metformin 19 (32) 20 (43) 0.21
Sulfonylureas 10 (17) 6 (13) 0.59
Fibrates 2 (3) 2 (4) 1.00
Values are mean  SD, n (%), or median (25th to 75th percentiles).
ACE ¼ angiotensin converting enzyme; ARBs ¼ angiotensin receptor blockers; BMI ¼ body mass
index; ECG ¼ electrocardiographic; HDL ¼ high-density lipoprotein; LA ¼ left atrial; LDL ¼
low-density lipoprotein; LVEF ¼ left ventricular ejection fraction; POAF ¼ post-operative atrial
ﬁbrillation; SR ¼ sinus rhythm; TG ¼ triglycerides.Results
Demographic and clinical characteristics. The demo-
graphic and clinical characteristics of the study population are
presented in Table 1. A total of 104 patients were included
in the study. During the 8-day follow-up, AF developed in
46 patients after CABG surgery (44.2%). Patients in
whom POAF developed had a signiﬁcantly higher BMI
and pre-operative heart rate than patients who remained in
SR. There was a trend for older age in POAF patients. No
signiﬁcant differences in other demographic, clinical, or
paraclinical characteristics or pre-operative medications were
observed between patients with metabolic syndrome in
whom AF developed and those who remained in SR.
Pre-operative mitochondrial function in atrial tissue. In
permeabilized cardiac ﬁbers, ADP-stimulated mitochondrial
respiration rates supported by either pyruvate malate
(adenosine diphosphate–stimulated respiration supported by
pyruvate and malate) or palmitoyl-L-carnitine (VpalmþADP)
and complex IV–related uncoupled maximum respiration
(VCox) were signiﬁcantly lower in pre-operative atrial
myocardium from patients in whom POAF developed
compared with those who remained in SR (Fig. 1B). By
contrast, ADP-stimulated complex II–dependent respira-
tion was not different between groups (Fig. 1B).
Pre-operative atrial tissues had similar citrate synthase
activity in patients in whom POAF developed and those
who remained in SR (Table 2). This suggests that altered
respiration was likely not related to a modiﬁcation in
mitochondrial content, although mitochondrial DNA or
total FCCP-induced respiration were not measured in this
study. In vitro, complex IIþIII and complex III activities
(complex activity normalized by citrate synthase) were
signiﬁcantly reduced in POAF patients compared with those
who remained in SR, in contrast to complex I and IV
activities (Table 2).
The mCRC was signiﬁcantly decreased in patients with
POAF compared with patients who remained in SR
(Fig. 2A). Lower mCRC suggests that sensitivity to
calcium-induced mPTP opening was increased in patients in
whom POAF developed.
Measurements of ROS levels in frozen tissue assessed by
electron paramagnetic resonance spectroscopy and mito-
chondrial MnSOD activity were increased in patients in
whom POAF developed (Figs. 2B and 2C). Catalase activity
was not signiﬁcantly different in atrial biopsy specimens
from both groups (Fig. 2D).Multivariate logistic regression. To understand the
impact of pre-operative medication and clinical factors on
the association between pre-operative mitochondrial
dysfunction (i.e., reduced ADP-stimulated mitochondrial
respiration supported by palmitoyl-L-carnitine [VpalmþADP]),
and POAF, multivariate stepwise logistic regression analysis
was performed using backward variable selection. Using this
model, VpalmþADP and heart rate were independently asso-
ciated with POAF onset. Table 3 lists associations between
POAF and those parameters. BMI, age, and beta-blocker,
Table 2
In Vitro Mitochondrial Chain Complex Activities According to
Post-Operative Atrial Fibrillation Onset
Substrate Citrate Synthase Complex I
Complex
II þ III Complex III Complex IV
SR 201  56 7.3  1.2 13.6  1.4 32  5 60  8
POAF 180  73 5.9  1.5 7.9  1* 24  3* 56  7
Values are mean  SD. Citrate synthase activity in nmol∙min1∙mg1. Complex activities as percentage of citrate synthase activity. *p < 0.05
versus sinus rhythm.
Abbreviations as in Table 1.
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1470and statin use were not individually predictive of the
occurrence of AF after cardiac surgery.
Gene expression proﬁle associated with POAF onset.
Global mRNA expression patterns of atrial biopsies from
8 diabetic patients with no POAF matched with 8 diabetic
patients with POAF were measured using high-density
oligonucleotide arrays. After ﬁltering data on expression (20%
to 100%) to remove minimally expressed genes, a volcano plot
graph was generated with a fold change cutoff at 1.2 (Online
Fig. 1 in Online Appendix 1). A total of 615 genes (for
p ¼ 0.05) and 67 genes (for p ¼ 0.01) were found to be
differentially expressed in patients in whom POAF developed.
The gene list, as exported from GeneSpring, was sorted in
Excel based on the level (fold change values) of regulation of
POAF (down or up) (OnlineAppendix 2). The top 10 up- andFigure 2
Mitochondrial Permeability Transition Pore Opening Sensiti
in Whom POAF Is or Is Not Developing
(A) Mitochondrial calcium retention capacity (mCRC) determined as the capacity of mitoc
explored for each of the 104 patients. (B) Reactive oxygen species (ROS) concentration in a
in atrial tissue. Values are presented as mean  SD or median, 25th to 75th percentiles, adown-regulated genes are presented according to HUGO
GeneNomenclatureCommittee database inOnlineFigure 1 in
Online Appendix 1.
Up- or down-regulated genes were classiﬁed using the
functional annotation table in Database for Annotation,
Visualization, and IntegratedDiscovery (DAVID). Although
such a classiﬁcation did not reveal any signiﬁcant func-
tionally relevant groups in up-regulated genes, down-
regulated genes identiﬁed a functional group of genes involved
in mitochondria/oxphos processes (Fig. 3). In addition,
several expressed genes involved in oxidation/reduction
reactions were altered in POAF patients, such as glutathione-
S-transferase, thioredoxin, heme oxidase, peroxiredoxin,
cytochrome p-450, and xanthine dehydrogenase (Online
Appendix 1).vity and Myocardial Oxidative Stress in Patients
hondria to uptake calcium before permeability transition. Five to seven ﬁbers were
trial tissue. Manganese superoxide dismutase (MnSOD) (C) and catalase (D) activity
nd range. n ¼ 83 to 104 patients. *p< 0.05 versus SR. Abbreviations as in Figure 1.
Table 3
Pre-Operative Variables Associated With
Post-Operative Atrial Fibrillation Onset
Coefﬁcient SD p Value
VpalmþADP, per unit 0.314 0.144 0.028
Heart rate, beats/min 0.065 0.031 0.048
Coefﬁcients and SDs are given for continuous variables.
VpalmþADP ¼ adenosine diphosphate–stimulated respiration supported by palmitoyl-L-carnitine
(in pmolO2∙s1∙mg dry wt1).
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1471Discussion
The present translational study provides the ﬁrst direct
evidence of a role of perturbations of cardiac mitochondrial
function in clinical arrhythmia pathophysiology. More
speciﬁcally, our results suggest that pre-operative mito-
chondrial dysfunction of the atrial myocardium may be an
important determinant of AF risk after CABG surgery in
patients with metabolic syndrome. We provide data arguing
for a transcriptional downregulation of the oxidative phos-
phorylation (OXPHOS)/mitochondrial genes as a mecha-
nism of this mitochondrial dysfunction in diabetic patients
with metabolic syndrome in whom POAF develops.
Mitochondria and arrhythmia. The heart is a tissue with
one of the highest rates of energy conversion in the body,
being critically dependent on mitochondrial oxidative
phosphorylation as a major source of ATP (16). Thus,
cardiac mitochondria represent a key actor of the biological
systems addressed to prevent any mismatch between ATP
production and use and thus any major disruption in the
energy available for function.
Potential roles of mitochondria in cardiac electrical
function have recently emerged from in vitro studies
showing that modulations of the mitochondrial respiration,
membrane potential, and ion channels alter sarcolemmal ion
channels involved in action potential genesis. Inhibition of
the mitochondrial respiratory chain by antimycin A, a
complex III inhibitor, or by an increased ratio between the
reduced and the oxidized form of the intracellular nicotin-
amide adenine dinucleotide, has been shown to inhibit the
sarcolemmal sodium current in cardiomyocytes (5,6). Brown
et al. (17) showed that cardiac arrhythmias in isolated
perfused heart induced by glutathione oxidation can be
inhibited by ligands of the mitochondrial benzodiazepine
receptor, which stabilize mitochondrial membrane potential
and prevent mitochondrial depolarization. In accordance,
our study identiﬁed elements of mitochondrial dysfunction
(i.e., impairment in maximal capacity to oxidize both
carbohydrate- and lipid-based substrates and increased
sensitivity to mPTP opening) associated with arrhythmia
onset in patients. The sarcolemmal KATP channel and
adenosine monophosphate protein kinase are sensors of
cellular energy levels that have been reported as candidates
for the downstream mediators of metabolic stress, namely,
the link between cardiomyocyte excitability and mitochon-
drial metabolism (3,4). Their speciﬁc role in POAF was not
tested here and warrants further investigation.POAF and mitochondrial dysfunction in the metabolic
syndrome. In case-control studies, Anderson et al. (13,18)
and Niemann et al. (19) showed that mitochondrial func-
tion is abnormal in the atrial myocardium of obese patients
and/or those with diabetes. Our prospective study provides
data showing that this mitochondrial dysfunction is mean-
ingful and associated with clinically relevant events in patients
with metabolic syndrome.
The exact pathologicalmechanisms responsible for the onset
and perpetuation of POAF are incompletely understood.
POAF-facilitating factors are typically separated into acute
factors directly related to surgery (i.e., inﬂammation, ischemia
injury, beta-adrenergic activation) and factors that reﬂect
chronic and progressive cardiac remodeling (7). Pre-existing
factors can initiate AF and/or aggravate the underlying
conditions able to perpetuate AF. Among these latter factors
are alterations in cellular Ca2þ and Kþ ion channels, age-
dependent atrial remodeling, and structural heart diseases (7).
Indirect evidence suggests a role for altered energy metabolism
in POAF pathology. In case-control studies, lower oxidative
phosphorylation and altered expression of genes involved in
cardiacmitochondrial energy production have been observed in
human atrial biopsy specimens from patients with chronic AF
(20,21). Using a permeabilized ﬁber approach on atrial tissue
obtained before CABG surgery and thus before arrhythmia
onset, we demonstrate here thatmitochondrial respiration rates
supported by both carbohydrate- and lipid-based substrates are
reduced in patients in whom AF developed compared with
those who remained in SR.Consistently, the individual activity
of complex IIþIII was reduced in frozen atrial biopsy speci-
mens from POAF patients. Taking into account the estab-
lished biological and clinical mediators of AF, we demonstrate
that reduced mitochondrial respiration is an independent
predictor of POAF. Mitochondria-targeted tools such as
mitochondria-targeting antioxidants and myocardial pre-
conditioning should be tested as promising strategies in POAF
prevention in patients with metabolic syndrome.
Mechanisms of cardiac mitochondrial dysfunction in
patients in whom POAF develops. Recent evidence shows
that increased ROS production and, more speciﬁcally,
increased superoxide anion production derived from the atrial
nicotinamide adenine dinucleotide phosphate oxidase are
independently associated with a higher risk of POAF (22,23).
In line with these studies, we found that high levels of ROS
production in pre-operative biopsy specimens discriminated
between patients in whom AF developed from those who
maintained SR in the post-operative period. We also iden-
tiﬁed several differentially expressed genes in POAF patients.
A signiﬁcantly enriched cluster of down-regulated genes is
involved in oxidation/reduction reactions and contributes to
cellular oxidative stress. In addition, atrial tissue from patients
in whom POAF developed exhibited an upregulation of
mitochondrial MnSOD activity and an increased sensitivity
of mPTP opening. Both can be regarded as indirect evidence
of increased mitochondria-targeted ROS. If mitochondrial
oxidases are not a major source of ROS in POAF, as observed
Figure 3
Altered Expressed Genes in Atrial Samples From 8 Diabetic Patients With No POAF Matched With
8 Diabetic Patients With POAF
(A) Gene Ontology (GO)-term enrichment analysis of down-regulated genes in post-operative atrial ﬁbrillation (POAF) patients. Ofﬁcial gene symbols corresponding to down-
regulated genes (fold change >1.2, p < 0.05) were uploaded into the Database for Annotation, Visualization, and Integrated Discovery (DAVID) portal and analyzed using
medium stringency. Top-ranking annotations according to the Biological Process Functional Annotation Tool (BP FAT) and the Protein Information Resource (PIR) keywords are
shown. Count: number of genes included (% involved genes/total genes). P Value: modiﬁed Fisher exact test p value. ATP ¼ adenosine triphosphate. (B) Representative scheme
of genes altered in the “oxidative phosphorylation” functional pathway (Kyoto Encyclopedia of Genes and Genomes [KEGG] pathway). *indicates signiﬁcant down-regulated gene
expression in POAF patients versus patients in SR. Gene count is 21 (8.3%) with a p value of 1.1E15. All abbreviations correspond to the ofﬁcial gene symbol. A detailed
description can be found at http://www.genecards.org/.
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1473by Reilly et al. (24), nicotinamide adenine dinucleotide
phosphate oxidase–derived ROS can target and damage
mitochondrial DNA and protein complexes, the observed
mitochondrial dysfunction being the link between previously
reported ROS imbalance and arrhythmia (1,2).
Transcriptomic analysis of mRNA from atrial biopsy
specimens from diabetic patients in whom AF developed in
the post-operative period revealed that nuclear and mito-
chondrial genes involved in mitochondria/OXPHOS
processes were down-regulated. Molecular mechanisms for
this concomitant down-regulation of OXPHOS have not
been identiﬁed. Several hypotheses, warranting further inves-
tigation, can be put forward to explain this phenomenon. An
upstream transcriptional regulator controlling this OXPHOS
network may be altered in diabetic cardiomyocytes. Alterna-
tively, but not exclusively, the microRNA expression pattern
may be altered in the clinical situations associated with POAF.
Study limitations. The present study does not prove
a causal association between mitochondrial dysfunction and
POAF; therefore, further mechanistic studies are required.
Concerning our statistical analysis, the sample size may have
limited our ability to fully account for clinical factors, and the
multivariate model is slightly overﬁtted. Finally, our results
of a monocentric study are restricted to patients with
metabolic syndrome who were selected because of their high
susceptibility to AF after CABG surgery and marked alter-
ations of cardiac mitochondria in their atrial myocardium.
Although the population studied is representative of nearly
50% of patients referred to the hospital for CABG surgery,
our results should be tested in the general population.
Conclusions
We demonstrate in a prospective study that pre-operative
mitochondrial dysfunction of the atrial myocardium is
associated with AF occurrence after cardiac surgery, identi-
fying the mitochondrium as a potential key player in clini-
cally relevant arrhythmia and thus as a new promising target
in POAF prevention strategies.
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